Capricor Therapeutics reported $59.63M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Bioline Rx BLRX:US $ 50.94M 6.46M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Capricor Therapeutics CAPR:US $ 59.63M 23.2M
Cytokinetics CYTK:US $ 623.53M 87.85M
Cytori Therapeutics CYTX:US $ 22.1M 2.38M
Geron GERN:US $ 175.92M 11.28M
Johnson & Johnson JNJ:US $ 60424M 555M
Newlink Genetics NLNK:US 92.64M 7.03M
Prothena PRTA:US 555.62M 29.19M
Ptc Therapeutics PTCT:US $ 774.01M 180.36M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Vascular Biogenics VBLT:US 46.52M 8.33M
Vital Therapies VTL:US $ 115.88M 10.89M